UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035069
Receipt number R000038386
Scientific Title Method to encourage consultation for people in Impaired Glucose Tolerance: a randomized control trial
Date of disclosure of the study information 2019/02/01
Last modified on 2021/06/03 09:45:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Method to encourage consultation for people in Impaired Glucose Tolerance: a randomized control trial

Acronym

to go see doc trial

Scientific Title

Method to encourage consultation for people in Impaired Glucose Tolerance: a randomized control trial

Scientific Title:Acronym

to go see doc trial

Region

Japan


Condition

Condition

Impaired Glucose Tolerance

Classification by specialty

Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to prevent diabetes mellitus, encourage people who are pointed out Impaired Glucose Tolerance at a comprehensive medical examination to go life style related consultation in early term.
1) Develop a decision aid to encourage people going consultation.
2) Confirm the efficacy of the decision aid.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A rate of people who go for medical consultation related to Impaired Glucose Tolerance.

Key secondary outcomes

(1) A rate of people who get worse of their Impaired Glucose Tolerance.
(2) Changing in blood sugar.
(3) Changing in HbA1c.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Intervention: new method of explanation

Interventions/Control_2

Control: conventional method of explanation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

(1) 20-75y-o at the point of the comprehensive medical check.
(2) Correspond one of followings.
a) HbA1c: 6.0-6.4%
b) Fasting blood sugar: 110-125 mg/dL
c) Blood sugar after two hours of oral glucose tolerance test: 140-199 mg/dL

Key exclusion criteria

(1) Undergoing treatment of Diabetes mellitus at the point of the comprehensive medical check.
(2) Not be proved the results of the comprehensive medical check in the test day.
(3) Need informed assent.
(4) Not agree with participating in the study.

Target sample size

490


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Kobayashi

Organization

Kyoto University

Division name

Agency for Health, Safety and Environment

Zip code

606-8501

Address

Yoshidahon-machi, Sakyo-ku, Kyoto

TEL

075-753-2415

Email

kobayashi.daisuke.2e@kyoto-u.ac.jp


Public contact

Name of contact person

1st name Manako
Middle name
Last name Konda

Organization

Kyoto University

Division name

School of Public Health Department of Preventive Services

Zip code

606-8501

Address

Yoshidahon-machi, Sakyo-ku, Kyoto

TEL

075-753-2431

Homepage URL


Email

konda.manako.53v@st.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Kyoto University Hospital Ethics Committee

Address

Yoshida Konoe-cho, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 09 Month 21 Day

Date of IRB

2018 Year 11 Month 29 Day

Anticipated trial start date

2019 Year 05 Month 17 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry

2021 Year 06 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 29 Day

Last modified on

2021 Year 06 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038386


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name